Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17682 | 587 | 31.0 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
109 | 2 | CHRONIC LYMPHOCYTIC LEUKEMIA//HODGKINS DISEASE//MANTLE CELL LYMPHOMA | 25223 |
17682 | 1 | SPLENIC MARGINAL ZONE LYMPHOMA//NODAL MARGINAL ZONE LYMPHOMA//MONOCYTOID B CELL LYMPHOMA | 587 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SPLENIC MARGINAL ZONE LYMPHOMA | authKW | 3102693 | 13% | 76% | 78 |
2 | NODAL MARGINAL ZONE LYMPHOMA | authKW | 917593 | 4% | 84% | 21 |
3 | MONOCYTOID B CELL LYMPHOMA | authKW | 833606 | 4% | 64% | 25 |
4 | MONOCYTOID B CELLS | authKW | 517115 | 2% | 76% | 13 |
5 | SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES | authKW | 495685 | 3% | 53% | 18 |
6 | SPLENIC LYMPHOMA | authKW | 481482 | 3% | 49% | 19 |
7 | MARGINAL ZONE LYMPHOMA | authKW | 437984 | 7% | 21% | 40 |
8 | SLVL | authKW | 433481 | 2% | 83% | 10 |
9 | SMZL | authKW | 383039 | 2% | 82% | 9 |
10 | INTRASINUSOIDAL INFILTRATION | authKW | 364127 | 1% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pathology | 10560 | 38% | 0% | 222 |
2 | Hematology | 6906 | 33% | 0% | 195 |
3 | Oncology | 1458 | 27% | 0% | 158 |
4 | Medical Laboratory Technology | 131 | 3% | 0% | 16 |
5 | Medicine, General & Internal | 83 | 7% | 0% | 42 |
6 | Surgery | 32 | 6% | 0% | 37 |
7 | Genetics & Heredity | 23 | 4% | 0% | 24 |
8 | Cell Biology | 17 | 5% | 0% | 29 |
9 | Medicine, Research & Experimental | 11 | 3% | 0% | 17 |
10 | Anatomy & Morphology | 3 | 1% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EQUIPE PATHOL CELLULES LYMPHOIDES | 216741 | 1% | 83% | 5 |
2 | BERLIN REFERENCE CONSULTAT LYMPHOMA HAEMA | 104036 | 0% | 100% | 2 |
3 | CONSULTAT REFERENCE HEMATOPATHOL | 69356 | 0% | 67% | 2 |
4 | EA 3737 | 69356 | 0% | 67% | 2 |
5 | AZIENDA OSPEDUO PATHOL 2 | 52018 | 0% | 100% | 1 |
6 | CELL TISSUE CETI | 52018 | 0% | 100% | 1 |
7 | CITOL HEMATOL CITOGENET MOLPATHOL | 52018 | 0% | 100% | 1 |
8 | CITOL HEMATOLGRP RECECA TRASLAC NEOPLASIES H | 52018 | 0% | 100% | 1 |
9 | CITOL HEMATOLIMASIMIM | 52018 | 0% | 100% | 1 |
10 | CLIN EXPT ONCO HEMATOL | 52018 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF HEMATOPATHOLOGY | 7919 | 1% | 4% | 4 |
2 | LEUKEMIA & LYMPHOMA | 6988 | 5% | 0% | 32 |
3 | HUMAN PATHOLOGY | 6294 | 5% | 0% | 31 |
4 | AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 6191 | 5% | 0% | 27 |
5 | HISTOPATHOLOGY | 4495 | 4% | 0% | 22 |
6 | AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 3820 | 4% | 0% | 25 |
7 | BRITISH JOURNAL OF HAEMATOLOGY | 2579 | 4% | 0% | 26 |
8 | HAEMATOLOGICA | 2404 | 2% | 0% | 13 |
9 | HEMATOLOGY AND CELL THERAPY | 2395 | 1% | 2% | 3 |
10 | MODERN PATHOLOGY | 2112 | 2% | 0% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SPLENIC MARGINAL ZONE LYMPHOMA | 3102693 | 13% | 76% | 78 | Search SPLENIC+MARGINAL+ZONE+LYMPHOMA | Search SPLENIC+MARGINAL+ZONE+LYMPHOMA |
2 | NODAL MARGINAL ZONE LYMPHOMA | 917593 | 4% | 84% | 21 | Search NODAL+MARGINAL+ZONE+LYMPHOMA | Search NODAL+MARGINAL+ZONE+LYMPHOMA |
3 | MONOCYTOID B CELL LYMPHOMA | 833606 | 4% | 64% | 25 | Search MONOCYTOID+B+CELL+LYMPHOMA | Search MONOCYTOID+B+CELL+LYMPHOMA |
4 | MONOCYTOID B CELLS | 517115 | 2% | 76% | 13 | Search MONOCYTOID+B+CELLS | Search MONOCYTOID+B+CELLS |
5 | SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES | 495685 | 3% | 53% | 18 | Search SPLENIC+LYMPHOMA+WITH+VILLOUS+LYMPHOCYTES | Search SPLENIC+LYMPHOMA+WITH+VILLOUS+LYMPHOCYTES |
6 | SPLENIC LYMPHOMA | 481482 | 3% | 49% | 19 | Search SPLENIC+LYMPHOMA | Search SPLENIC+LYMPHOMA |
7 | MARGINAL ZONE LYMPHOMA | 437984 | 7% | 21% | 40 | Search MARGINAL+ZONE+LYMPHOMA | Search MARGINAL+ZONE+LYMPHOMA |
8 | SLVL | 433481 | 2% | 83% | 10 | Search SLVL | Search SLVL |
9 | SMZL | 383039 | 2% | 82% | 9 | Search SMZL | Search SMZL |
10 | INTRASINUSOIDAL INFILTRATION | 364127 | 1% | 100% | 7 | Search INTRASINUSOIDAL+INFILTRATION | Search INTRASINUSOIDAL+INFILTRATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MATUTES, E , (2013) SPLENIC MARGINAL ZONE LYMPHOMA: DISEASE FEATURES AND MANAGEMENT.EXPERT REVIEW OF HEMATOLOGY. VOL. 6. ISSUE 6. P. 735-745 | 49 | 91% | 6 |
2 | MATUTES, E , OSCIER, D , MONTALBAN, C , BERGER, F , CALLET-BAUCHU, E , DOGAN, A , FELMAN, P , FRANCO, V , IANNITTO, E , MOLLEJO, M , ET AL (2008) SPLENIC MARGINAL ZONE LYMPHOMA PROPOSALS FOR A REVISION OF DIAGNOSTIC, STAGING AND THERAPEUTIC CRITERIA.LEUKEMIA. VOL. 22. ISSUE 3. P. 487 -495 | 54 | 75% | 96 |
3 | ARCAINI, L , ROSSI, D , PAULLI, M , (2016) SPLENIC MARGINAL ZONE LYMPHOMA: FROM GENETICS TO MANAGEMENT.BLOOD. VOL. 127. ISSUE 17. P. 2072 -2081 | 60 | 63% | 0 |
4 | KALPADAKIS, C , PANGALIS, GA , VASSILAKOPOULOS, TP , SACHANAS, S , ANGELOPOULOU, MK , (2014) TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA: SHOULD SPLENECTOMY BE ABANDONED?.LEUKEMIA & LYMPHOMA. VOL. 55. ISSUE 7. P. 1463 -1470 | 39 | 89% | 3 |
5 | KALPADAKIS, C , PANGALIS, GA , ANGELOPOULOU, MK , SACHANAS, S , VASSILAKOPOULOS, TP , (2016) CURRENT AND EMERGING TREATMENT APPROACHES FOR SPLENIC MARGINAL ZONE LYMPHOMA.EXPERT OPINION ON ORPHAN DRUGS. VOL. 4. ISSUE 9. P. 897 -905 | 49 | 65% | 0 |
6 | PIRIS, MA , ARRIBAS, A , MOLLEJO, M , (2011) MARGINAL ZONE LYMPHOMA.SEMINARS IN DIAGNOSTIC PATHOLOGY. VOL. 28. ISSUE 2. P. 135-145 | 45 | 74% | 6 |
7 | OSCIER, D , OWEN, R , JOHNSON, S , (2005) SPLENIC MARGINAL ZONE LYMPHOMA.BLOOD REVIEWS. VOL. 19. ISSUE 1. P. 39-51 | 50 | 72% | 44 |
8 | KALPADAKIS, C , PANGALIS, GA , ANGELOPOULOU, MK , SACHANAS, S , KONTOPIDOU, FN , YIAKOUMIS, X , KOKORIS, SI , DIMITRIADOU, EM , DIMOPOULOU, MN , MOSCHOGIANNIS, M , ET AL (2013) TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA WITH RITUXIMAB MONOTHERAPY: PROGRESS REPORT AND COMPARISON WITH SPLENECTOMY.ONCOLOGIST. VOL. 18. ISSUE 2. P. 190-197 | 31 | 89% | 15 |
9 | TRAVERSE-GLEHEN, A , BASEGGIO, L , SALLES, G , FELMAN, P , BERGER, F , (2011) SPLENIC MARGINAL ZONE B-CELL LYMPHOMA: A DISTINCT CLINICOPATHOLOGICAL AND MOLECULAR ENTITY. RECENT ADVANCES IN ONTOGENY AND CLASSIFICATION.CURRENT OPINION IN ONCOLOGY. VOL. 23. ISSUE 5. P. 441 -448 | 32 | 91% | 19 |
10 | VAN DEN BRAND, M , VAN KRIEKEN, JHJM , (2013) RECOGNIZING NODAL MARGINAL ZONE LYMPHOMA: RECENT ADVANCES AND PITFALLS. A SYSTEMATIC REVIEW.HAEMATOLOGICA. VOL. 98. ISSUE 7. P. 1003-1013 | 48 | 56% | 15 |
Classes with closest relation at Level 1 |